QC
TXG icon

Quadrature Capital’s 10x Genomics TXG Stock Holding History

Quadrature Capital’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$740K Buy
+19,293
New +$506K 0.01% 845
2025
Q2 		– Sell
-13,932
Closed -$122K – 1515
2025
Q1 		$122K Buy
+13,932
New +$176K ﹤0.01% 917
2024
Q3 		– Sell
-42,755
Closed -$830K – 1399
2024
Q2 		$830K Buy
+42,755
New +$1.12M 0.01% 507

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Quadrature Capital's TXG Position: Q2 2026 in Review

Quadrature Capital opened a new position in 10x Genomics (TXG) in Q2 2026: 19,293 shares worth $740K. The stake represents 0.01% of the portfolio and ranks #845 among its holdings. This is a return to the name: Quadrature Capital previously reported a position in TXG as recently as Q1 2025.

Quadrature Capital first reported a position in TXG in Q2 2024 and has held it in 3 quarters since. The position peaked at $830K in Q2 2024. 393 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Quadrature Capital held 19,293 shares of 10x Genomics worth $740K as of Q2 2026.
  • 10x Genomics was a new Quadrature Capital position in Q2 2026.
  • 10x Genomics made up 0.01% of Quadrature Capital's portfolio in Q2 2026, its #845 holding.
  • Quadrature Capital first reported a position in 10x Genomics in Q2 2024 and has held it in 3 quarters since.
  • Quadrature Capital's 10x Genomics position peaked at $830K in Q2 2024.
  • 393 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.